Marrone Bio Innovations to Report Third Quarter 2020 Results on Monday, November 9th at 4:30 p.m. Eastern Time
October 26 2020 - 8:31AM
Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an
international leader in providing growers with sustainable
bioprotection and plant health solutions to support global
agricultural needs, will release financial results for the third
quarter ended September 30, 2020, after market close on Monday,
November 9, 2020 at 4:30 p.m. Eastern time.
Management will host an investor conference call
at 4:30 p.m. ET (1:30 p.m. PT) on November 9, 2020 to discuss
Marrone Bio Innovations’ third quarter 2020 financial results,
provide a corporate update, and conclude with a Q&A from
participants. To participate, please use the following
information:
Q3
2020 Conference Call and Webcast Date: Monday,
November 9, 2020Time: 1:30 p.m. Pacific time (4:30 p.m. Eastern
time)U.S. Dial-in: 1-800-437-2398International Dial-in:
1-323-289-6576Conference ID: 1021625Webcast:
http://public.viavid.com/index.php?id=141814
Please dial in at least 10 minutes before the
start of the call to ensure timely participation.
A playback of the call will be available through
December 9, 2020. To listen, call 1-844-512-2921 within the United
States or 1-412-317-6671 when calling internationally. Please use
the replay pin number 1021625. A webcast will also be available for
30 days on the IR section of the Marrone Bio Innovations website or
by clicking here: MBII Q3 2020 Webcast.
About Marrone
Bio InnovationsMarrone Bio Innovations Inc.
(NASDAQ: MBII) is a growth-oriented company leading the movement to
a more sustainable world through the discovery, development and
sale of innovative biological products for crop protection, plant
health and waterway systems treatment that help customers operate
more sustainably while increasing their return on investment. MBI
has screened over 18,000 microorganisms and 350 plant extracts,
leveraging its in-depth knowledge of plant and soil microbiomes
enhanced by advanced molecular technologies and natural product
chemistry to rapidly develop seven product lines. Supported by a
robust portfolio of over 400 issued and pending patents, MBI’s
currently available commercial products are Regalia®, Stargus®,
Grandevo®, Venerate®, Majestene®, Haven®, Pacesetter™, Zelto® Jet
Oxide® and Jet Ag® and Zequanox®, with a next-generation
insecticide-nematicide, a breakthrough bioherbicide and a
biofumigant in the Company’s product pipeline. MBI’s Pro Farm
Finland-based subsidiary employs a proprietary technology derived
from wood waste to stimulate plant growth and improve plant health,
resulting in improved yields and crop quality. Products include
UBP™ 110, Foramin®, UBP™ Seed Treatment, Foramin® ST.Learn more
about Marrone Bio Innovations at www.marronebio.com. We also use
our investor relations website, https://investors.marronebio.com,
as well as our corporate Twitter account, @Marronebio, as means of
disclosing material non-public information, and encourage our
investors and others to monitor and review the information we make
public in these locations. Follow us on social media: Twitter,
LinkedIn and Instagram.
Marrone Bio Innovations
Forward Looking StatementsThis press release contains
forward-looking statements that involve substantial risks and
uncertainties. All statements, other than statements of historical
facts, included in this press release regarding strategy, future
operations and plans, including assumptions underlying such
statements, are forward-looking statements, and should not be
relied upon as representing MBI’s views as of any subsequent
date. Examples of such statements include statements regarding
the search process for a new CFO and the timing of Mr. Boyd’s
retirement. Such forward-looking statements are based on
information available to the Company as of the date of this release
and involve a number of risks and uncertainties, some beyond the
Company’s control, that could cause actual results to differ
materially from those anticipated by these forward-looking
statements, including the recent uncertainty in the global economy
and industry-specific economy caused by the COVID-19 pandemic,
consumer, regulatory and other factors affecting demand for the
Company’s products, weather, regulatory and other factors affecting
demand for the MBI’s products, any difficulty in marketing MBI’s
products in its target markets, competition in the market for pest
management products, lack of understanding of bio-based pest
management products by customers and growers, and adverse decisions
by regulatory agencies and other relevant third parties. Additional
information that could lead to material changes in MBI’s
performance is contained in its filings with the SEC. MBI is under
no obligation to, and expressly disclaims any responsibility to,
update or alter forward-looking statements contained in this
release, whether as a result of current information, future events
or otherwise.
Company Contact:Kevin Helash, Chief Executive
OfficerPhone: 530-750-2800info@marronebio.com
Investor Relations Contact:Greg Falesnik or
Luke ZimmermanMZ Group – MZ North AmericaPhone:
949-385-6449MBII@mzgroup.us
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Mar 2024 to Apr 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Apr 2023 to Apr 2024